What Prostall treats: main uses and benefits

Prostall is a specialized nutritional formulation designed to support the physiological health of the prostate gland. It is primarily utilized by men seeking to maintain normal urinary function and prostate wellness as they age.

Main Uses

The product is intended to address the nutritional requirements associated with male reproductive health. Its primary applications include:

• Support for Urinary Flow: Helping to maintain a consistent and healthy urinary stream.
• Bladder Function: Assisting in the management of bladder emptying and reducing the frequency of nighttime urination.
• Prostate Health Maintenance: Providing essential nutrients that support the integrity and normal size of the prostate gland.

Benefits

The formulation works by providing a blend of amino acids and specific nutrients that are naturally present in healthy prostate tissue. The key benefits associated with its use include:

• Reduced Urgency: Helping to manage the sudden urge to urinate, which often contributes to improved daily comfort.
• Improved Quality of Life: By addressing common urinary concerns, the formulation helps minimize disruptions to daily activities and sleep patterns.
• Nutritional Supplementation: Delivering a targeted complex of glutamic acid, alanine, and glycine, which are involved in the metabolic processes of the prostate.

Prostall serves as a supportive measure for maintaining the functional efficiency of the male urinary tract and is used to promote long-term prostate stability.

Regulatory References

1. NIH MedlinePlus overview on Proton Pump Inhibitors

Official Eligibility Profile

The eligibility for Prostall is strictly defined by regulatory documents, which approve the medicine exclusively for adult male patients. The drug is not indicated for use in women or the pediatric population (under 18 years of age), as safety and effectiveness have not been established in these groups.

Absolute Non-Eligibility (Contraindications)

Prostall must not be used by patients with the following conditions:

• A known hypersensitivity to tamsulosin hydrochloride or any other component in the capsule.
• A history of orthostatic hypotension (low blood pressure upon standing).
• Severe hepatic insufficiency (severe liver impairment).

Restricted and Conditional Use

Certain conditions require caution or special consideration before use:

• Severe Renal Impairment: Caution is necessary, as use in patients with severe kidney function problems (end-stage renal disease) has not been studied.
• Eye Surgery: Initiation of therapy is not recommended for patients scheduled for cataract or glaucoma surgery due to the potential for Intraoperative Floppy Iris Syndrome (IFIS).
• Prostate Screening: Patients must be screened for the presence of prostate cancer before starting treatment and at regular intervals afterward.

Prostall Interactions with other medicines and products

Interactions between medicines occur when one drug alters the absorption, metabolism, or effect of another, potentially changing its efficacy or increasing the risk of adverse effects. It is essential to discuss all concurrent medications, including prescription drugs, over-the-counter products, and herbal supplements, with a healthcare provider before starting treatment with Prostall.

While specific, officially documented interaction data for the proprietary drug name Prostall is not widely available in core regulatory documents, certain substance classes may be involved in pharmacokinetic (PK) or pharmacodynamic (PD) interactions common to its likely active ingredient category.

Interactions that may warrant caution include combinations that:

• Impact Blood Coagulation: Combining Prostall with anticoagulants, such as warfarin, may increase the International Normalized Ratio (INR) and the risk of bleeding. Close monitoring of coagulation parameters may be necessary.
• Alter Drug Metabolism: Medicines that induce or inhibit liver enzymes, particularly the cytochrome P450 system (e.g., CYP3A4 inhibitors like certain antifungals or antivirals), may alter the concentration of Prostall in the body, potentially increasing the risk of side effects.
• Increase Risk of Muscle Effects: Co-administration with other lipid-modifying agents, such as fibrates or high-dose niacin, may increase the potential for muscle-related toxicity, including rhabdomyolysis.

Patients should also be cautious about concurrent use of supplements like St. John's Wort, which can affect the body's processing of many medicines. The overall interaction profile necessitates individualized assessment by a qualified health professional.

The mechanism of Prostall is defined by the highly selective antagonism of alpha1 adrenergic receptors, particularly the alpha1A and alpha1D subtypes. This action directly targets the signaling pathway mediated by the neurotransmitter norepinephrine, which is responsible for stimulating smooth muscle contraction in the lower urinary tract. By binding to these receptors, Prostall competitively blocks the transmission of the sympathetic signal.

The molecular blockade initiates a cascade by inhibiting the Gq protein signaling pathway that typically follows alpha1 receptor activation. This inhibition prevents the necessary release of intracellular calcium ions ( Ca^2+) within the smooth muscle cells of the prostate and bladder neck. The resulting physiological effect is the relaxation of this muscle tissue, thereby decreasing the dynamic resistance to fluid movement.

Prostall's mechanism is focused on altering smooth muscle tone (dynamic resistance) and does not engage the pathways responsible for tissue growth or size reduction (static resistance). This highly focused mechanism of functional blockade means that its action addresses the muscular tension component, while its activity extends peripherally to also affect vascular smooth muscle alpha1 receptors.

How Prostall is Used

Prostall is a prescription-only pharmaceutical preparation administered via the oral route as a 0.4 mg modified-release capsule. This form is designed for a once daily (QD) dosing schedule.

Dosing and Administration Principles

The standard pattern for use involves taking the dose consistently with a meal each day. Administration is typically performed approximately one-half hour following the same meal to ensure stable absorption and drug levels.

The modified-release capsule must be swallowed whole and must not be chewed, crushed, or opened. Violating this restriction compromises the intended controlled-release mechanism of the medication.

Dosage Regimen

The usual starting dose for adults is 0.4 mg once daily. If clinical assessment determines that the initial dose is insufficient, the amount may be increased to the maximum recommended daily dose of 0.8 mg once daily, typically following a period of 2 to 4 weeks. If therapy is interrupted for several days, treatment should be restarted at the initial 0.4 mg dose.

No specific dose adjustment is generally required for patients with mild to moderate renal or hepatic impairment. Prostall is not indicated for use in pediatric populations.

Research Evidence / Overview of Studies

---

Early Research and Pharmacokinetics

Research explored the potential role of a specific enzyme in the progression of the condition. Preclinical studies focused on determining the drug's basic pharmacological profile, including absorption, metabolism, and excretion in animal models. Initial in-vitro studies evaluated the compound's selectivity for a targeted pathway, and Phase I trials examined dose-finding and pharmacokinetic parameters in healthy volunteers.

Core Efficacy Findings (Phase II/III)

Clinical trials evaluated measured changes in symptoms across a defined patient population. Primary outcome measures typically involved standardized scores for disease severity. Key studies investigated whether the combination could be associated with a reduction in reported pain and explored the onset of its measured effects.

• Phase II data suggested a dose-response relationship, with higher doses being associated with a greater proportion of patients meeting the criteria for clinical response.
• The studies investigated changes in flare-up frequency over time compared to a placebo group.

Safety Profile and Long-Term Use

The trials examined the overall safety profile; reported adverse events were mostly mild and transient. Long-term extension studies were designed to monitor safety and tolerability over several years. Adverse event reporting across all trials has been compiled to establish a comprehensive safety summary. Researchers investigated whether the combination was associated with changes in the overall quality of life.

Comparative Studies and Current Research Focus

Limited research has directly compared this drug to other established therapies. A meta-analysis reported findings that suggested potential benefits in a specific sub-type of the condition. This approach is being investigated as part of research into second-line therapies following initial treatments. Current research is focused on identifying biomarkers that may predict which patients are most likely to respond to this treatment.

Common questions about Prostall (FAQ)

---

Q: How quickly does Prostall usually start working?

Studies and official product information indicate that the full effect of Prostall on improving urine flow may take a few days of regular daily dosing to be achieved. It may take up to five days before the full effect on urine flow is noted.

---

Q: Are there known interactions between Prostall and common allergy medications?

Regulatory documents state that Prostall may interact with certain medicines that are commonly found in allergy or congestion products. These components, known as sympathomimetics, could potentially lead to an increase in blood pressure when combined with this medicine.

---

Q: Does Prostall interact with common blood pressure medicines?

Caution is advised in the official prescribing information when Prostall is taken with other medicines used to treat high blood pressure. Combining these drug types can potentially lower blood pressure too much, a situation that may warrant monitoring.

---

Q: Can Prostall affect fertility in men or women?

Prostall is not indicated for use in women or in the pediatric population. Regarding men, the official adverse reactions list includes 'abnormal ejaculation,' which is described as problems with semen being released (little or no semen). This is a functional change but is not specifically defined as infertility.

---

Q: Does Prostall interact with antacids?

Official information does not list a specific interaction with a broad class of antacids. However, Prostall is a modified-release capsule, and the requirement is in place to support stable absorption by taking it consistently with a meal.

---

Q: Can Prostall be used by people with kidney problems?

Regulatory information addresses the use of Prostall in patients with reduced kidney function. No specific dose adjustment is generally required for patients with mild to moderate kidney impairment. However, official information notes that use in patients with severe or end-stage renal disease has not been studied.

---

Q: Are there any common side effects people mention when first starting Prostall?

According to official safety documents, orthostatic symptoms, such as dizziness or vertigo, are detected more frequently when beginning treatment with the medicine. Official information describes these as symptoms detected more frequently when beginning treatment.

---

Q: Is it normal to feel a difference right away after taking Prostall?

Prostall is designed to work over time to provide symptomatic relief. Studies and official information indicate that it may take several days of consistent dosing—up to five days—to achieve the full, measurable effect on urine flow.

---

Q: Can Prostall be taken along with common over-the-counter pain relievers?

The official drug interaction section advises caution when combining Prostall with certain non-steroidal anti-inflammatory drugs (NSAIDs). These NSAIDs may affect how quickly the medicine is removed from the body.

---

Q: Is Prostall meant to be a long-term treatment?

The research evidence overview indicates that clinical trials included long-term extension studies designed to monitor the medicine's safety and tolerability over several years.

---

Q: What happens if I forget to take Prostall sometimes?

Official regulatory documents contain specific guidance for managing a single missed dose, including an instruction about not taking two doses at the same time to compensate. This information is available in the official prescribing documents.

---

Q: Is there a generic version of Prostall available?

Yes, the active ingredient in Prostall is Tamsulosin hydrochloride. The official records confirm that approved generic versions of Tamsulosin are available.

---

Q: Is Prostall known to interact with herbal supplements?

Official documents state that there is limited testing on the effect of herbal remedies on this medicine, and caution is necessary. Disclosure of all concurrent supplements is necessary to allow for an individualized assessment.

---

Q: Can Prostall affect my ability to drive or operate machinery?

Because common side effects include dizziness or light-headedness, the labeling includes a caution about driving, operating machinery, or performing hazardous tasks for patients experiencing dizziness or light-headedness.

---

Q: Has Prostall been approved in other countries besides the US?

The active ingredient in Prostall, Tamsulosin, is widely approved. It is marketed under various brand and generic names in many countries, including Canada and member states of the European Union.

---

Q: Is it okay to drink alcohol while taking Prostall?

Official warnings state that alcohol can increase the medicine's blood pressure-lowering effect. This interaction may lead to symptoms like increased dizziness or light-headedness.

---

Q: Why do some people experience mild dizziness with Prostall?

Dizziness is a common side effect of Prostall, which is classified as an alpha-adrenergic receptor antagonist. This type of medicine works by relaxing smooth muscles, and this effect can extend to blood vessels, potentially causing dizziness.

---

Q: Is Prostall a scheduled or controlled substance?

No, according to official classification records, Prostall is a prescription-only medicine. It is not classified as a scheduled or controlled substance in the United States.

---

Q: Are there any specific warnings about taking Prostall before surgery?

The official labeling includes a specific safety note concerning a condition called Intraoperative Floppy Iris Syndrome (IFIS). This complication may occur during cataract or glaucoma surgery in patients who are using or have previously used this class of medication.

---

Q: Are there any dietary restrictions mentioned in the official prescribing information for Prostall?

The prescribing information requires the medicine to be taken consistently with a meal to ensure stable absorption. Beyond general warnings about avoiding alcohol, the official documentation does not specify broad dietary restrictions.

---

Q: Does Prostall interact with grapefruit?

Prostall is metabolized, or broken down, by certain liver enzymes (CYP3A4). Caution is advised when consuming substances, such as grapefruit, that inhibit these enzymes, as this interaction may increase the amount of medicine in the body.

---

Q: Can Prostall be taken with vitamins or mineral supplements?

Official drug interaction documents state that vitamins and mineral supplements are generally not formally tested for their effect on this medicine. As with all supplements, this information is necessary for a complete professional assessment.

---

Q: Does Prostall interact with anticoagulants?

The medicine may interact with anticoagulants, such as warfarin. Official documents advise that close monitoring of blood coagulation parameters may be necessary when these medicines are used together.

How to Store and Dispose of Prostall?

Storage Scope	Requirement
Temperature	Store at 20 C to 25 C (68 F to 77 F), with permitted excursions between 15 C and 30 C.
Protection	Keep in the original container, tightly closed, and protect from excess heat and moisture.
Child Safety	The medication must be kept out of the sight and reach of children.
Disposal	Unused or expired Prostall must be disposed of according to local regulations, preferably through a drug take-back program.

The official storage conditions define a mandatory Controlled Room Temperature environment to maintain product stability. Prostall must be stored in its original, sealed container and kept away from common hazards like heat and moisture. When discarding the medication, do not flush it down the toilet or place it in household trash unless mixing guidelines are followed, as defined by health authorities.